Your Article Summary
See Latest ArticlesA Case of Intrauterine Growth Restriction in Association with Placental Mesenchymal Dysplasia with Abnormal Placental Lymphatic Development
Placenta, 06/29/09
Heazell AEP et al. - Immunostaining reveals they are not of trophoblast or vascular endothelial origin. There is positive immunostaining for lymphatic endothelium; this abnormal lymphangiogenesis is in concordance with current hypotheses regarding the aetiology of PMD. Furthermore, such observations suggest that placental villous mesenchyme may differentiate into various cell types, even those not normally found in the human placenta.
Related Articles
Comparison of dysplasia profiles in stimulated ovaries and in those with a genetic risk for ovarian cancer
European Journal of Cancer, 10/20/09
Relevance Score: 46%
Placental malaria among HIV-infected and uninfected women receiving anti-folates in a high transmission area of Uganda
Malaria Journal, 11/16/09
Relevance Score: 45%
Precancerous anal lesions may be very common in some populations: protease inhibitor therapy may help
AIDSmap, 11/17/09
Relevance Score: 43%
Multipotent mesenchymal stromal cell therapy in renal disease and kidney transplantation
Nephrology Dialysis Transplantation, 11/05/09
Relevance Score: 43%
Grading of gastric foveolar-type dysplasia in Barrett's esophagus
Modern Pathology, 10/23/09
Relevance Score: 43%
Today in Fetal Development...keeping you current
Receive free subspecialty "5-minute updates" via email
Recent advances in our understanding of protein and amino acid metabolism in the human fetus
Current Opinion in Clinical Nutrition & Metabolic Care, 12/14/09
Sex and the Human Placenta: Mediating Differential Strategies of Fetal Growth and Survival
Placenta, 12/14/09
Using Z-scores to compare biometry data obtained during prenatal ultrasound screening by midwives and physicians
Prenatal Diagnosis, 12/11/09